Issue 11, 2021, Issue in Progress

Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

Abstract

Retraction of ‘Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4’ by Pengwei Lu et al., RSC Adv., 2018, 8, 8455–8468, DOI: 10.1039/C8RA00296G

Associated articles

Article information

Article type
Retraction
Submitted
25 Jan 2021
Accepted
25 Jan 2021
First published
02 Feb 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 5895-5895

Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

L. Fisher, RSC Adv., 2021, 11, 5895 DOI: 10.1039/D1RA90067F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements